Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous tumor, resulting a challenge of developing target therapeutics. Not long ago, immune checkpoint blockade regimens combine with tyrosin kinase inhibitors have evolved frontline options in metastatic RCC, which implies arriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Zhuangyao, Yao, Haohua, Wei, Jinhuan, Feng, Zihao, Chen, Wei, Luo, Junhang, Chen, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100830/
https://www.ncbi.nlm.nih.gov/pubmed/33968649
http://dx.doi.org/10.21037/tau-20-1348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100830/
https://www.ncbi.nlm.nih.gov/pubmed/33968649
http://dx.doi.org/10.21037/tau-20-1348

Ejemplares similares